Cross-Sectional and Time-Dependent Analyses on Inflammatory Markers following Natural Killer Cell Activity

The function of natural killer (NK) cells in inflammation has not been explored enough in large-scale population studies. The cross-sectional and time-dependent relationship between NK cell activity (NKA) and inflammatory markers was examined. Methods: A total of 7031 subjects were involved in the cross-sectional analyses. Non-linear relationship between NKA and inflammatory indices was analyzed using generalized additive models. The time-dependent changes were analyzed in 1005 subjects with repeated measurement in 3–6 months. The changes in inflammatory markers were analyzed based on the changes in NKA. Results: As NKA reduces to a very low level, the white blood cell (WBC) and neutrophil counts increase sharply, and the lymphocyte count exhibits a slow decline. With increasing NKA larger than about 500 pg/mL, WBC and neutrophil-lymphocyte ratio (NLR) reduces in a mild slope. Among the subjects with repeated measurements, the follow-up NKA was increased with advancing baseline NKA levels. The subjects with a reduction in NKA indicated increment in WBC count, neutrophil count, and NLR, and decrease in lymphocyte count. Conclusions: Very low levels of NKA suggest a high inflammatory immune response. The changes in NKA may interact with the balance between neutrophils and lymphocytes.

[1]  Sang-Woon Choi,et al.  Vitamin D and Exercise Are Major Determinants of Natural Killer Cell Activity, Which Is Age- and Gender-Specific , 2021, Frontiers in Immunology.

[2]  M. Helmy,et al.  The diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in COVID-19: a systematic review and meta-analysis , 2021, Expert review of molecular diagnostics.

[3]  Y. Hu,et al.  [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[4]  J. C. Cohen Tervaert,et al.  Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19 , 2020, Blood Advances.

[5]  J. C. Cohen Tervaert,et al.  Natural Killer Cell Dysfunction and Its Role in COVID-19 , 2020, International journal of molecular sciences.

[6]  Li Yang,et al.  Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage , 2020, Journal of Translational Medicine.

[7]  L. Nadauld,et al.  An elevated neutrophil-to-lymphocyte ratio associates with weight loss and cachexia in cancer , 2020, Scientific Reports.

[8]  K. Egan,et al.  Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer , 2019, Scientific Reports.

[9]  Pawan Kumar,et al.  Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis , 2019, Front. Immunol..

[10]  Kyoung-Ah Kim,et al.  Clinical utility of a novel natural killer cell activity assay for diagnosing non-small cell lung cancer: a prospective pilot study , 2019, OncoTargets and therapy.

[11]  K. Kim,et al.  Association of neutrophil‐to‐lymphocyte ratio and natural killer cell activity revealed by measurement of interferon‐gamma levels in a healthy population , 2018, Journal of clinical laboratory analysis.

[12]  Y. Bryceson,et al.  Natural killer cells in inflammation and autoimmunity. , 2018, Cytokine & growth factor reviews.

[13]  T. Hansen,et al.  Quantification of NK cell activity using whole blood: Methodological aspects of a new test. , 2018, Journal of immunological methods.

[14]  S. Oudard,et al.  Optimal cut-off for neutrophil-to-lymphocyte ratio: Fact or Fantasy? A prospective cohort study in metastatic cancer patients , 2018, PloS one.

[15]  G. Jobin,et al.  Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy. , 2017, Gastroenterology.

[16]  G. Lal,et al.  The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy , 2017, Front. Immunol..

[17]  C. Park,et al.  Natural killer cell activity for IFN-gamma production as a supportive diagnostic marker for gastric cancer , 2017, Oncotarget.

[18]  J. Barkin,et al.  Association between natural killer cell activity and prostate cancer: a pilot study. , 2017, The Canadian journal of urology.

[19]  Sarah E. Ewald,et al.  Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration , 2017, Front. Immunol..

[20]  N. Rose,et al.  Natural killer cells in inflammatory heart disease. , 2017, Clinical immunology.

[21]  R. Weinberg,et al.  Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells. , 2016, Cancer discovery.

[22]  A. Pera,et al.  Proinflammatory status influences NK cells subsets in the elderly. , 2014, Immunology letters.

[23]  I. Tannock,et al.  Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. , 2014, Journal of the National Cancer Institute.

[24]  Guangyu Zhang,et al.  Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies. , 2014, Atherosclerosis.

[25]  Sang Woo Park,et al.  A high-throughput assay of NK cell activity in whole blood and its clinical application. , 2014, Biochemical and biophysical research communications.

[26]  S. Clarke,et al.  The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. , 2013, Critical reviews in oncology/hematology.

[27]  J. Lewis,et al.  Evaluation of a Flow Cytometry‐Based Assay for Natural Killer Cell Activity in Clinical Settings , 2012, Scandinavian journal of immunology.

[28]  Baptiste N. Jaeger,et al.  Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis , 2012, The Journal of experimental medicine.

[29]  C. Fauriat,et al.  Molecular Mechanisms of Natural Killer Cell Activation , 2011, Journal of Innate Immunity.

[30]  A. D. de Craen,et al.  White blood cell count and C-reactive protein are independent predictors of mortality in the oldest old. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[31]  Eric O Long,et al.  Regulation of human NK-cell cytokine and chemokine production by target cell recognition. , 2010, Blood.

[32]  S. Maher,et al.  Interferon: cellular executioner or white knight? , 2007, Current medicinal chemistry.

[33]  Eric O Long,et al.  Activation, coactivation, and costimulation of resting human natural killer cells , 2006, Immunological reviews.

[34]  J. Ernerudh,et al.  Loss of natural killer cell activity in patients with coronary artery disease. , 2005, Atherosclerosis.

[35]  Mark B Pepys,et al.  C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.

[36]  Kazuyoshi Takeda,et al.  New aspects of natural-killer-cell surveillance and therapy of cancer , 2002, Nature Reviews Cancer.

[37]  K. Nakachi,et al.  Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population , 2000, The Lancet.

[38]  G. Ruhenstroth-Bauer,et al.  Erythrocyte sedimentation rate and C-reactive protein , 1976, Klinische Wochenschrift.

[39]  M. Feldman,et al.  C-reactive protein and erythrocyte sedimentation rate discordance: frequency and causes in adults. , 2013, Translational research : the journal of laboratory and clinical medicine.

[40]  E. Oda,et al.  Comparison between high-sensitivity C-reactive protein (hs-CRP) and white blood cell count (WBC) as an inflammatory component of metabolic syndrome in Japanese. , 2010, Internal medicine.

[41]  U. Koszinowski,et al.  Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. , 2003, Immunity.